Delivery Order SPE2DB22D2206-SPE2DB25FKC06
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $35,881.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with an ultimate completion date of October 20, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $239,208.40, represents a competitively awarded, non-set-aside contract with a completion deadline of October 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $11,960.42, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with a contract ceiling value of $478,416.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by October 6, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This is a firm fixed price, non-competitive delivery order with a completion date of July 29, 2025, issued on July 8, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 units in 15ml quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the contractor based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of September 25, 2025, and represents a standard pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This non-set-aside competitive award carries a ceiling value of $35,881.26 and is scheduled for completion by September 30, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC06Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with completion targeted for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's DLA IDC enables supply of a broad range of medications and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for Darzalex Faspro, a specialty oncology medication, exemplifies the contractor's role in supporting critical pharmaceutical requirements within the federal medical supply chain and reflects DLA's strategy of utilizing prime vendor contracts for flexible, comprehensive pharmaceutical support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.6k | 9/24/25 |